RESEARCH TRIANGLE PARK, N.C., Nov. 15, 2017 -- Charles & Colvard, Ltd. (NASDAQ:CTHR), the original and leading worldwide source of created moissanite, announced that Suzanne Miglucci, President and CEO, and Clint J. Pete, Chief Financial Officer, will present at the 10th Annual LD Micro Main Event Conference and the Benchmark Micro Cap Discovery One-on-One Conference.
The LD Micro Main Event Conference will be held December 5-7, 2017 at the Luxe Sunset Boulevard Hotel in Los Angeles. During this event, Miglucci and Pete will be available for one-on-one meetings with institutional investors on December 5. The Benchmark Micro Cap Discovery One-on-One Conference will be held on December 14, 2017 at the Palmer House Hilton in Chicago. Management will also be available for one-on-one meetings with institutional investors during this conference. Interested investors should contact conference representatives to schedule a meeting.
The investor presentation provided at the conferences will be posted in the Investor Relations section of the Company’s website: http://ir.charlesandcolvard.com/events.
About Charles & Colvard, Ltd.
Charles & Colvard, Ltd., based in the Research Triangle Park area of North Carolina, is the original creator and leading source of Forever One™, Forever Brilliant® and Forever Classic™ moissanite gemstones for fine jewelry. Moissanite is unique, available in three color grades (colorless, near-colorless and faint color) and produced from silicon carbide (SiC) crystals. Charles & Colvard Created Moissanite® is sold with a Limited Lifetime Warranty to wholesale distributors, manufacturers, retailers, TV shopping networks, and designers as loose stones or set in a wide variety of quality metal setting options. Charles & Colvard, Ltd. also sells direct to consumers through its wholly owned operating subsidiary, charlesandcolvard.com, LLC and through third-party marketplaces. Charles & Colvard, Ltd.’s common stock is listed on the NASDAQ Capital Market under the symbol “CTHR.” For more information, please visit www.charlesandcolvard.com.
Contacts:
Clint J. Pete
Chief Financial Officer
919-468-0399
[email protected]
Investor Relations:
Taglich Brothers, Inc.
Christopher Schreiber
212-661-6886


Innovent Biologics Shares Rally on New Eli Lilly Oncology and Immunology Deal
xAI Co-Founder Jimmy Ba Departs as Elon Musk’s AI Startup Faces Turbulence
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
Canadian Airlines Suspend Cuba Flights Amid Jet Fuel Shortage and U.S. Sanctions
Kroger Set to Name Former Walmart Executive Greg Foran as Next CEO
Samsung Electronics Sees Sustained AI-Driven Demand for Memory Chips Into Next Year
Indian Refiners Scale Back Russian Oil Imports as U.S.-India Trade Deal Advances
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning
Lyft Shares Slide After Weak Q1 Profit Forecast and Surprise 2025 Operating Loss
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
Moderna Stock Drops After FDA Declines Review of mRNA Flu Vaccine
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
SpaceX Pivots Toward Moon City as Musk Reframes Long-Term Space Vision
Standard Chartered Names Peter Burrill as Interim Group CFO Following Diego De Giorgi’s Exit
Salesforce Workforce Reduction Affects Fewer Than 1,000 Roles Amid Ongoing Restructuring
Anta Sports Expands Global Footprint With Strategic Puma Stake
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates 



